AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Beta Drugs Limited Call Transcript 2024

Nov 4, 2024

61112_rns_2024-11-04_2f0cf775-3ad3-4fe2-832b-e9fbbdf755ce.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [538 x 118] intentionally omitted <==

BDL/PKL/SEC/2024 4[th] November, 2024

National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot no. C/l, G Block Bandra-Kurla Complex, Bandra (E) Mumbai — 400 051.

SYMBOL-BETA

Sub: Earnings conference call to discuss Operational and Financial performance H1 FY25.

Dear Sir,

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Management of our Company will be hosting an Earnings conference call to discuss Operational and Financial performance H1 FY25 on Thursday, 7[th] November, 2024.

Thanking You Your’s faithfully For Beta Drugs Ltd. Rajni Digitally signed by Rajni Brar Date: 2024.11.04 Brar 17:50:27 +05'30' Rajni Brar Company Secretary

==> picture [490 x 100] intentionally omitted <==